OTC Herbal and Traditional Medicines Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Herbal medicines are naturally derived medicines for treatment of various ailments. These generally represent medicines sourced from medicinal herbs, or, plants. Traditional medicines are sum of practices, skills, and knowledge based on experiences, beliefs, and theories indigenous to various cultures, used for prevention, and maintenance of health. Various types of herbal and traditional medicines include Chinese/oriental medicines, naturopathy, homeopathy, and Ayurveda.

According to a recent research by Fact.MR, the global OTC herbal and traditional medicines market is estimated to exhibit a moderate expansion at a CAGR of 4.8% during the forecast period 2017 to 2022. The global market for OTC herbal and traditional medicines will account for revenues over US$ 20,000 Mn in 2017. Revenues from the market are further estimated to exceed US$ 30,000 Mn by 2022-end.

Market Taxonomy

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Increasing Concerns among Consumers about Integrity of Synthetic Drugs will Drive Demand for OTC Herbal and Traditional Medicines

Traditional and herbal systems of medicines have always played a crucial role in meeting the requirements of the global health care. According to the Ministry of AYUSH, India, a rising trend towards Ayurveda, Yoga, and Unani is being witnessed across the globe. Increasing concerns of consumers pertaining to the integrity of synthetic drugs has led them towards adoption of traditional and herbal medicines, creating huge opportunities for manufacturers. The consumer health sector has been witnessing transformations, where principles of traditional medicines are being rediscovered, and introduced to cater the rising consumer demand for natural prevention and treatment options. This in turn is expected to pave a new opportunity for manufacturers, who are facing problems pertaining to safety of synthetic OTC drugs. The aforementioned factors are projected to augment growth of the global OTC herbal and traditional medicines market.

Although traditional and herbal systems of medicines comprise of valuable elements, they also contain ingredients that are harmful and result into side-effects. Two aspects for their safety evaluation considered are no adulteration/contamination, and right quality of ingredients. This necessitates doctor’s prescription before use of traditional and herbal medicines, which may hinder growth of the market. A slew of well-maintained research centres such as India’s AYUSH, and Dabur Research & Development Center are focusing on R&D related to traditional and herbal medicines, especially Ayurvedic medicines. The transforming healthcare environment worldwide is in dire need for the comprehensive policy review of herbal and traditional systems of medicine.

APEJ to Remain Dominant in the Global OTC Herbal and Traditional Medicines Market

Asia Pacific excluding Japan (APEJ) is anticipated to be dominant in the market in 2017, and the trend is expected to witness a steady growth through 2022. North America is estimated to be the second largest market for OTC herbal and traditional medicines by 2022-end. Japan will continue to be the least lucrative region in the global OTC herbal and traditional medicines market.

Based on function, sales of OTC herbal and traditional medicines in maintaining digestive health of people are expected to account for the largest revenues by 2022-end. Sales of OTC herbal and traditional medicines for nutrition, and bone & joint health are expected to exhibit a parallel expansion at similar CAGRs, however, revenues from sales for nutrition will remain comparatively higher than that from bone & joint health.

Modern Trade OTC Channel to Remain Sought-After among Consumers in the Global Market

Modern trade OTC channel will remain sought-after among consumers for purchasing of OTC herbal and traditional medicines, with sales expected to register a steady expansion through 2022. In addition, sales of OTC herbal and traditional medicines through online OTC channel will register the highest CAGR over the forecast period. Although, pharmacy OTC channel will account for a larger revenue share of the market, sales are anticipated to exhibit a sluggish expansion through 2022.

Powder dosage of OTC herbal and traditional medicines will continue to be preferred among consumers, with sales poised to surpass US$ 10,000 Mn by 2022-end. Between tablet and liquid dosage of OTC herbal and traditional medicines, tablet dosage will account for a larger revenue share, while sales of liquid dosage will exhibit a higher CAGR through 2022.

Competition Tracking

According to the report, the companies that will remain active in expansion of global OTC herbal and traditional medicine market include Amway Corporation, Herbalife International, The Himalayan Drug Company, Naturex SA, Blackmores Limited, Nutraceutical International Corporation, The Nature's Bounty Co., Bio-Botanica, Inc., The Bioforce Group, Ricola AG, Bionorica SE, Integria Healthcare Pty Ltd., Jiaherb Inc., Nutra Green Biotechnology Co., Ltd., Biovontrade SARL, Dabur India Ltd., Phytomed Herbal Solutions, and Medico Herbs.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR